RxDoctor Payments Data

Nimish Mohile, MD

Neurology · Rochester, NYNPI 1487857967

Payments from drug & device makers

$97,296in general payments, 2019–2025

Across 65 payments — averaging $1496.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure GmbH$97K
  • Biogen$565

What the payments were for

  • Consulting fees$565100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novocure GmbH64$96,731
Biogen1$565

How this compares

$97,296 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York

Medicare billing

Part B allowed, 2024
$24,786
Medicare patients
105
Services billed
214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam35$851
Dexamethasone30$462
Gabapentin11$260

Paid to pharmacies, not to this prescriber.

Other neurology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →